These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10556172)

  • 1. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease.
    Macnee W; Rahman I
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S58-65. PubMed ID: 10556172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidants/antioxidants and chronic obstructive pulmonary disease: pathogenesis to therapy.
    MacNee W
    Novartis Found Symp; 2001; 234():169-85; discussion 185-8. PubMed ID: 11199095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidants/antioxidants and COPD.
    MacNee W
    Chest; 2000 May; 117(5 Suppl 1):303S-17S. PubMed ID: 10843965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease?
    MacNee W; Rahman I
    Trends Mol Med; 2001 Feb; 7(2):55-62. PubMed ID: 11286755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.
    MacNee W
    Proc Am Thorac Soc; 2005; 2(1):50-60. PubMed ID: 16113469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
    Rahman I
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease.
    Lin JL; Thomas PS
    COPD; 2010 Aug; 7(4):291-306. PubMed ID: 20673039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases.
    Rahman I
    J Biochem Mol Biol; 2003 Jan; 36(1):95-109. PubMed ID: 12542980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms.
    Rahman I
    Cell Biochem Biophys; 2005; 43(1):167-88. PubMed ID: 16043892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of oxidants/antioxidants in smoking-induced lung diseases.
    Rahman I; MacNee W
    Free Radic Biol Med; 1996; 21(5):669-81. PubMed ID: 8891669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms.
    Lakhdar R; Denden S; Kassab A; Leban N; Knani J; Lefranc G; Miled A; Chibani JB; Khelil AH
    Exp Lung Res; 2011 Aug; 37(6):364-75. PubMed ID: 21721950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking.
    Nowak D; Kasielski M; Antczak A; Pietras T; Bialasiewicz P
    Respir Med; 1999 Jun; 93(6):389-96. PubMed ID: 10464820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
    Kirkham P; Rahman I
    Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the oxidant and antioxidant balance in the pathogenesis of chronic obstructive pulmonary disease.
    Cristóvão C; Cristóvão L; Nogueira F; Bicho M
    Rev Port Pneumol; 2013; 19(2):70-5. PubMed ID: 23199890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance.
    Mak JC
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):368-74. PubMed ID: 18371260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant therapeutic targets in COPD.
    Rahman I; Kilty I
    Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and lung inflammation in airways disease.
    MacNee W
    Eur J Pharmacol; 2001 Oct; 429(1-3):195-207. PubMed ID: 11698041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
    Praticò D; Basili S; Vieri M; Cordova C; Violi F; Fitzgerald GA
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1709-14. PubMed ID: 9847257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The levels of oxidant and antioxidant in patients with COPD].
    Altuntaş E; Turgut T; Ilhan N; Deveci F; Muz HM; Celik I
    Tuberk Toraks; 2003; 51(4):373-9. PubMed ID: 15143384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
    Rahman I
    Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.